FDA Drops Black Box Warning on Pfizer's Anti-Smoking Drug

FDA Drops Black Box Warning on Pfizer's Anti-Smoking Drug
AP Photo/Mark Lennihan, File

U.S. health regulators on Friday allowed Pfizer Inc to remove a serious warning from the label of its smoking cessation treatment, Chantix, giving a new lease of life to the controversial drug that was approved a decade ago.



Comment
Show comments Hide Comments


Related Articles